ArticleCancer2020
Disparities in risk perception of thyroid cancer recurrence and death.
Article in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.
- 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer.Thyroid : official journal of the American Thyroid Association · 2025Guideline
- Contemporary management of differentiated thyroid cancer in Latin America: results from the CaTaLiNA prospective multicenter registry.Endocrine · 2026Article
- Fear of cancer recurrence in papillary thyroid cancer: a comparison across ATA risk groups and influencing factors.Endocrine · 2026Article
- Machine learning-based prediction model for Fear of progression in thyroid cancer survivors.Endocrine · 2026Article
- Changes in the frequency of postoperativeSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Health-related quality of life and predictors in differentiated thyroid cancer patients during the transitional period: A Cross-sectional study.Endocrine · 2026Article
- Making Choices: A Multi-institutional, Longitudinal Cohort Study Assessing Changes in Treatment Outcome Valuation for Low-risk Thyroid Cancer.Annals of surgery · 2025Article
- Cancer-related Fear and Worry in Patients With Low-risk Thyroid Cancer: A Longitudinal Cohort Study.The Journal of clinical endocrinology and metabolism · 2025Article
- Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.BMC cancer · 2024Article
- Social Determinants of Health and Disparities in Thyroid Care.The Journal of clinical endocrinology and metabolism · 2024Article
- Article
- Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study.Thyroid : official journal of the American Thyroid Association · 2024Article
- Quality of Life in Patients With Well-Differentiated Thyroid Carcinoma After Total Thyroidectomy in Greece.Cureus · 2024Article
- Nomogram to predict the risk of biochemical recurrence and structural recurrence in patients with stage cN1 papillary thyroid carcinoma.Journal of cancer research and clinical oncology · 2023Article
- Social Determinants of Health and Quality of Life in Endocrine Surgery Patients.The Journal of surgical research · 2023Article
- The "not so good" thyroid cancer: a scoping review on risk factors associated with anxiety, depression and quality of life.Journal of medicine and life · 2023Article
- Knowledge, Awareness and Perception towards Thyroid Cancer in General Population: A Systematic Review.Iranian journal of public health · 2023Review
- Change in worry over time among Hispanic women with thyroid cancer.Journal of cancer survivorship : research and practice · 2022Article
- Disparities in Thyroid Care.Endocrinology and metabolism clinics of North America · 2022Review
- SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition.Cell death & disease · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 1 country.
Funding
Abstract
backgroundTo the authors' knowledge, studies regarding risk perception among survivors of thyroid cancer are scarce.
methodsThe authors surveyed patients who were diagnosed with differentiated thyroid cancer from the Surveillance, Epidemiology, and End Results registries of Georgia and Los Angeles County (2632 patients; 63% response rate). The analytic cohort was defined by a ≤5% risk of disease recurrence and mortality (1597 patients). Patients estimated their recurrence and mortality risks separately (increments of 10% and endpoints of ≤5% and ≥95%). Both outcomes were dichotomized between reasonably accurate estimates (risk perception of ≤5% or 10%) versus overestimation (risk perception of ≥20%). Multivariable logistic regression was used to identify factors associated with risk overestimation, and the relationships between overestimation and both worry and quality of life were evaluated.
resultsIn the current study sample, 24.7% of patients overestimated their recurrence risk and 12.5% overestimated their mortality risk. A lower educational level was associated with overestimating disease recurrence (≤high school diploma: odds ratio [OR], 1.64 [95% CI, 1.16-2.31]; and some college: OR, 1.36 [95% CI, 1.02-1.81]) and mortality (≤high school diploma: OR, 1.86 [95% CI, 1.18-2.93]) risk compared with those attaining at least a college degree. Hispanic ethnicity was found to be associated with overestimating recurrence risk (OR, 1.44, 95% CI 1.02-2.03) compared with their white counterparts. Worry about recurrence and death was found to be greater among patients who overestimated versus those who had a reasonably accurate estimate of their risk of disease recurrence and mortality, respectively (P < .001). Patients who overestimated mortality risk also reported a decreased physical quality of life (mean T score, 43.1; 95% CI, 41.6-44.7) compared with the general population.
conclusionsLess educated patients and Hispanic patients were more likely to report inaccurate risk perceptions, which were associated with worry and a decreased quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.